Business Context and Reporting Period
This Form 6-K filing by Globant S.A. reports on the outcomes of the Annual General Meeting (AGM) and Extraordinary General Meeting (EGM) held on May 4, 2015. The filing was submitted on May 6, 2015. The meetings addressed the approval of financial statements for fiscal years 2013 and 2014, director elections, auditor appointments, and a significant amendment to the company's authorized share capital.
Key Financial Metrics
The filing discloses specific financial results for the fiscal year ended December 31, 2014, but does not provide detailed revenue, cash flow, or debt metrics.
- Net Loss (FY 2014): USD $5,628,285.23 (acknowledged and carried forward to the next financial year).
- Authorized Share Capital (Post-EGM): USD $5,109,380.40 (excluding issued share capital).
- Issued Share Capital: Represented by 4,257,817 common shares with a nominal value of USD $1.20 each.
- Other Metrics: The filing text does not provide clear values for revenue, operating margins, cash flow, or total debt.
Material Changes and Corporate Actions
The primary material change reported is the increase in authorized share capital approved at the EGM. Key actions include:
- Capital Increase: Shareholders approved an increase in authorized share capital to USD $5,109,380.40.
- Pre-emptive Rights Waiver: The Board of Directors was authorized to issue shares without reserving pre-emptive subscription rights for existing shareholders for a period of five years from the publication of the EGM minutes.
- Financial Statement Approval: Shareholders approved consolidated accounts under IFRS/IFRS EU for 2013 and 2014, and annual accounts under Lux GAAP for 2014.
- Board Composition: The mandates of directors Francisco Álvarez-Demalde, Bradford Eric Bernstein, and Phillip Odeen were renewed until 2018. David J. Moore was appointed as a new director for a term expiring in 2018.
- Auditor Appointment: Deloitte Audit was reappointed for annual accounts, and Deloitte & Co S.A. was appointed for consolidated accounts for the 2015 fiscal year.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future business performance. The document focuses strictly on the ratification of past financial results and corporate governance actions. No specific risks or contingencies were detailed in this text, other than the standard authorization for the Board to issue shares at their discretion, which may impact existing shareholder dilution.
Investor Verification Checklist
- Verify the impact of the new authorized share capital on potential dilution, given the Board's five-year waiver of pre-emptive rights.
- Review the full 2014 Annual Report (Form 20-F) to understand the drivers behind the reported net loss of approximately USD $5.6 million.
- Confirm the specific terms and conditions of the new director appointments and their compensation packages approved for 2015.
- Check subsequent filings for any actual issuance of shares under the new authorization granted at the EGM.